JYG Med: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
JYG Med
Largest movements
- Cash +€23,814
up €23,814 (+60.3%), from €39,494 to €63,307
mainly Provisions (+€27,173) and Net result for the year (+€16,110)
- Tangible fixed assets +€4,026
up €4,026 (+82.9%), from €4,859 to €8,885
- Provisions +€27,173
new in 2025: €27,173
- Reserves +€16,110
up €16,110 (+51.1%), from €31,521 to €47,631
- Other debts -€7,200
down €7,200 (-100%), from €7,200 to €0
- Tax, wage and social debts -€6,416
down €6,416 (-75.0%), from €8,552 to €2,136
- Trade debts -€1,802
down €1,802 (-52.8%), from €3,411 to €1,609
- Provisions +€27,173
new in 2025: €27,173
- Taxes -€2,843
down €2,843 (-20.3%), from €13,979 to €11,136
- Depreciation -€2,640
down €2,640 (-65.8%), from €4,013 to €1,373
- Gross operating margin -€873
down €873 (-1.5%), from €57,714 to €56,841
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €55,684 | €83,564 | +€27,880 | +50.1% |
| Fixed assets | 21/28 | €4,859 | €8,885 | +€4,026 | +82.9% |
| Tangible fixed assets | 22/27 | €4,859 | €8,885 | +€4,026 | +82.9% |
| Furniture and vehicles | 24 | €4,859 | €8,885 | +€4,026 | +82.9% |
| Current assets | 29/58 | €50,826 | €74,680 | +€23,854 | +46.9% |
| Amounts receivable within one year | 40/41 | €8,785 | €8,340 | -€445 | -5.1% |
| Other amounts receivable | 41 | €8,785 | €8,340 | -€445 | -5.1% |
| Cash at bank and in hand | 54/58 | €39,494 | €63,307 | +€23,814 | +60.3% |
| Deferred charges and accrued income | 490/1 | €2,547 | €3,032 | +€485 | +19.0% |
| Total equity and liabilities | 10/49 | €55,684 | €83,564 | +€27,880 | +50.1% |
| Equity | 10/15 | €36,521 | €52,631 | +€16,110 | +44.1% |
| Contributions | 10/11 | €5,000 | €5,000 | = | 0.0% |
| Reserves | 13 | €31,521 | €47,631 | +€16,110 | +51.1% |
| Distributable reserves | 133 | €31,521 | €47,631 | +€16,110 | +51.1% |
| Profit (loss) carried forward | 14 | €0 | €0 | = | |
| Provisions and deferred taxes | 16 | - | €27,173 | +€27,173 | |
| Provisions for liabilities and charges | 160/5 | - | €27,173 | +€27,173 | |
| Other liabilities and charges | 164/5 | - | €27,173 | +€27,173 | |
| Amounts payable | 17/49 | €19,163 | €3,760 | -€15,403 | -80.4% |
| Amounts payable within one year | 42/48 | €19,163 | €3,744 | -€15,419 | -80.5% |
| Trade debts | 44 | €3,411 | €1,609 | -€1,802 | -52.8% |
| Suppliers | 440/4 | €3,411 | €1,609 | -€1,802 | -52.8% |
| Taxes, remuneration and social security | 45 | €8,552 | €2,136 | -€6,416 | -75.0% |
| Taxes | 450/3 | €8,552 | €2,136 | -€6,416 | -75.0% |
| Other amounts payable | 47/48 | €7,200 | €0 | -€7,200 | -100% |
| Accrued charges and deferred income | 492/3 | - | €15 | +€15 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €4,013 | €1,373 | -€2,640 | -65.8% |
| Provisions for liabilities and charges: additions (uses and reversals) | 635/8 | - | €27,173 | +€27,173 | |
| Other operating charges | 640/8 | €112 | €202 | +€90 | +80.0% |
| Gross operating margin | 9900 | €57,714 | €56,841 | -€873 | -1.5% |
| Operating profit (loss) | 9901 | €53,588 | €28,093 | -€25,495 | -47.6% |
| Financial income | 75/76B | €231 | €432 | +€202 | +87.4% |
| Recurring financial income | 75 | €231 | €432 | +€202 | +87.4% |
| Financial charges | 65/66B | €1,119 | €1,279 | +€160 | +14.3% |
| Recurring financial charges | 65 | €1,119 | €1,279 | +€160 | +14.3% |
| Profit (loss) for the period before taxes | 9903 | €52,700 | €27,246 | -€25,454 | -48.3% |
| Income taxes | 67/77 | €13,979 | €11,136 | -€2,843 | -20.3% |
| Profit (loss) for the period | 9904 | €38,721 | €16,110 | -€22,611 | -58.4% |
| Profit (loss) for the period to be appropriated | 9905 | €38,721 | €16,110 | -€22,611 | -58.4% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 28 October 2026 via checked.be.